ipamorelin human clinical trial trials growth hormone secretion safety Figure 3 from Ipamorelin, the first selective secretagogue Ipamorelin 5mg – NewBioRx – ipamorelin clinical trial study – ipamorelin clinical trial growth hormone

Research suggests they may contribute to autism spectrum disorder (ASD) by interacting with neurodevelopmental proteins like NLGN4X and AChE, potentially disrupting synaptic function [3]

Research13 min read GLP-1 Agonists & Addiction: Emerging Research People taking [semaglutide](/peptides/semaglutide-complete-pharmacology-guide/) for weight loss or diabetes have been saying something unexpected for years now: they don't just want less food they want less alcohol, fewer cigarettes, and in some cases, less of whatever substance they'd been Research17 min read GLP-1 Agonists & Neurodegeneration Research Few topics in neuroscience have generated as much excitement -- and as much confusion -- as the idea that diabetes drugs might protect the brain from degenerative diseases

A high cellular antioxidant GSH concentration can protect the cells from oxidative stress

Glutathione reduces oxidative stress and inflammation which may play a role in treating irregular periods (2)

This formulation combines low molecular weight Copper Tripeptide-1 (GHK-Cu) at 99% purity with 11 additional peptides including Acetyl Hexapeptide-8 and Palmitoyl Pentapeptide-4